| |
|
|
|
Millendo Therapeutics Inc  
|
|
1.86 -0.14 (-0.07%) |
01-27 16:00 |
|
Open: |
1.97 |
Pre close: |
2 |
Target:
|
2.38 
|
|
High: |
1.9927 |
Low: |
1.85 |
Resistance:
|
2.04
2.33
|
|
Volume: |
737,811 |
Market Cap: |
35M |
Support:
|
1.56
1.30
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.93
|
MACD |
MACD(12,26):
|
-0.00 |
|
MA(20): |
1.86 |
Signal(12,26,9): |
-0.01  |
|
MA(100): |
1.74 |
Stochastic Oscillator |
%K(14,3):
|
72.77 |
|
MA(250): |
2.76 |
%D(3): |
67.97 |
|
Average Volume(K) |
3-Month: |
52193
|
52-Week |
High:
|
9.88 |
|
10-Days: |
68147 |
Low: |
1.26 |
|
RSI |
RSI(14):
|
48.23 |
Change(%): |
-78.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.348 |
Return on Equity (ttm) |
-98.6 |
Shares Out. (M) |
19.00 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-48.5 |
Shares Float (M) |
14.86 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
6.29 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
41.79 |
|
Forward EPS |
-3.250 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
404 |
|
Book Value (p.s.) |
2.060 |
EBITDA (p.s.) |
-2.183 |
P/E |
-0.79 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.90 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-36.82 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-19.44 |
P/CF |
-0.96 |
|
|
|
|
|
|
